EP0671950A4 - Immunologische reinigung von tumorzellen aus dem knochenmark mittels mikrosphären und monoklonalen antikörpern. - Google Patents

Immunologische reinigung von tumorzellen aus dem knochenmark mittels mikrosphären und monoklonalen antikörpern.

Info

Publication number
EP0671950A4
EP0671950A4 EP93923903A EP93923903A EP0671950A4 EP 0671950 A4 EP0671950 A4 EP 0671950A4 EP 93923903 A EP93923903 A EP 93923903A EP 93923903 A EP93923903 A EP 93923903A EP 0671950 A4 EP0671950 A4 EP 0671950A4
Authority
EP
European Patent Office
Prior art keywords
microspheres
immunological
purge
monoclonal antibodies
tumor cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP93923903A
Other languages
English (en)
French (fr)
Other versions
EP0671950A1 (de
Inventor
Stuart F Schlossman
Lee M Nadler
Arnold S Freedman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Publication of EP0671950A1 publication Critical patent/EP0671950A1/de
Publication of EP0671950A4 publication Critical patent/EP0671950A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061—Blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
EP93923903A 1992-10-19 1993-10-18 Immunologische reinigung von tumorzellen aus dem knochenmark mittels mikrosphären und monoklonalen antikörpern. Withdrawn EP0671950A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96310492A 1992-10-19 1992-10-19
US963104 1992-10-19
PCT/US1993/009891 WO1994008621A1 (en) 1992-10-19 1993-10-18 Immunological purging of tumor cells from bone marrow using microspheres and monoclonal antibodies

Publications (2)

Publication Number Publication Date
EP0671950A1 EP0671950A1 (de) 1995-09-20
EP0671950A4 true EP0671950A4 (de) 1996-07-31

Family

ID=25506759

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93923903A Withdrawn EP0671950A4 (de) 1992-10-19 1993-10-18 Immunologische reinigung von tumorzellen aus dem knochenmark mittels mikrosphären und monoklonalen antikörpern.

Country Status (5)

Country Link
EP (1) EP0671950A4 (de)
JP (1) JPH08502489A (de)
AU (1) AU681605B2 (de)
CA (1) CA2147010A1 (de)
WO (1) WO1994008621A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100124741A1 (en) * 2008-11-18 2010-05-20 Quest Disgnostics Investments Incorporated METHODS FOR DETECTING IgH/BCL-1 CHROMOSOMAL TRANSLOCATION
EP3527659A1 (de) * 2018-02-14 2019-08-21 Universidad del Pais Vasco Verfahren zur herstellung einer spermatozoidenzellpopulation mit verbesserter fitness

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005188A1 (en) * 1985-03-05 1986-09-12 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies and assay
WO1990010692A1 (en) * 1989-03-15 1990-09-20 University Of Florida Monoclonal antibody for use in detection and treatment of childhood leukemia

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986005188A1 (en) * 1985-03-05 1986-09-12 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies and assay
WO1990010692A1 (en) * 1989-03-15 1990-09-20 University Of Florida Monoclonal antibody for use in detection and treatment of childhood leukemia

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE FILE SEVER STN KARLSRUHE; BERREBI ET AL: "FURTHER CHARACTERIZATION OF PROLYMPHOCYTIC LEUKEMIA CELLS AS A TUMOR OF ACTIVATED B CELLS", XP002003405 *
DE FABRITIIS ET AL: "ELIMINATION OF CLONOGENIC BURKITT'S LYMPHOMA CELLS FROM HUMAN BONE MARROW USING 4-HYDROPEROXYCYCLOPHOSPHAMIDE IN COMBINATION WITH MONOCLONAL ANTIBODIES AND COMPLEMENT", BLOOD, vol. 65, no. 5, May 1985 (1985-05-01), pages 1064 - 1070, XP002003403 *
See also references of WO9408621A1 *
STASHENKO ET AL: "CHARACTERIZATION OF A HUMAN B LYMPHOCYTE-SPECIFIC ANTIGEN", THE JOURNAL OF IMMUNOLOGY, vol. 125, no. 4, October 1980 (1980-10-01), pages 1678 - 1685, XP002003404 *

Also Published As

Publication number Publication date
CA2147010A1 (en) 1994-04-28
AU681605B2 (en) 1997-09-04
AU5361694A (en) 1994-05-09
WO1994008621A1 (en) 1994-04-28
JPH08502489A (ja) 1996-03-19
EP0671950A1 (de) 1995-09-20

Similar Documents

Publication Publication Date Title
FI954347L (fi) Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat
EP0440619A4 (de) Antikörper gegen a4 amyloidpeptid.
IL87535A0 (en) Cell lines and monoclonal antibodies
GB8719587D0 (en) Monoclonal antibodies & peptides
IL88160A0 (en) Cell lines and monoclonal antibodies
EP0240344A3 (en) Monoclonal antibodies and their use
EP0307149A3 (en) Solid phase immunoassay for an antibody and biological constructions for use therein
IL90017A0 (en) Monoclonal antibodies
ZA921799B (en) Methods for selecting antibody reagents;anti-idiotype antibodies and aids vaccine formulations
ZA898777B (en) Monoclonal antibodies
GB8621910D0 (en) Monoclonal antibodies
EP0671950A4 (de) Immunologische reinigung von tumorzellen aus dem knochenmark mittels mikrosphären und monoklonalen antikörpern.
EP0511300A4 (en) Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
GB8804802D0 (en) Preparation of monoclonal antibodies
EP0586026A3 (de) Charakterisierung eines neuen Monoklonalen Anti-p110RB Antikörpers.
IL86960A0 (en) Preparation of human monoclonal antibodies
EP0508282A3 (en) Anti-idiotypic monoclonal antibodies
GB2207921B (en) Monoclonal antibody to omega-gliadin and hybridoma thereof
ZW9888A1 (en) Monoclonal antibodies and methods for diagnosis of pytophthora infection
EP0468056A4 (en) Anti-procollagenase monoclonal antibodies and a method for the assay of procollagenase utilizing thereof
GB8820036D0 (en) Monoclonal antibodies
GB8830115D0 (en) Monoclonal antibody and preparation and use thereof
GB8610202D0 (en) Monoclonal antibodies
GB8610203D0 (en) Monoclonal antibodies
IE892311L (en) Improved monoclonal antibodies

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950422

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19960614

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19980127